Geert Raes
Brussels, BRU 1050, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
VSIG4 Is Dispensable for Tumor Growth and Metastasis in Murine Colorectal and Breast Cancer Models.
Journal: Cancers
Published: August 22, 2025
Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq.
Journal: Nature communications
Published: February 13, 2025
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal Cavity.
Journal: European journal of immunology
Published: January 15, 2025
Imaging of tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 18, 2024
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.
Journal: Cancer research
Published: August 27, 2024
Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 26, 2024
Editorial: Immunometabolism in autoimmune and autoinflammatory disorders.
Journal: Frontiers in immunology
Published: August 30, 2023
Current status and future expectations of nanobodies in oncology trials.
Journal: Expert opinion on investigational drugs
Published: August 28, 2023
Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT.
Journal: Frontiers in immunology
Published: July 28, 2023
In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells.
Journal: Scientific reports
Published: April 02, 2023
A few good reasons to use nanobodies for cancer treatment.
Journal: European journal of immunology
Published: January 15, 2023
Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I).
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 24, 2022
Last Updated: 09/26/2026